Click to view our accessibility statement Skip to main content
By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.
This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.
This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences and hosted by Current Psychiatry.
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Hypothetical Patients
  4. 47-Year-Old Woman With Bipolar Depression
mind-td logo
The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.
  • About
  • Impact
  • Screening
  • Differential Diagnosis
  • Case Studies
  1. Home
  2. Case Studies
  3. Hypothetical Patients
  4. 47-Year-Old Woman With Bipolar Depression

Case Studies

47-Year-Old Woman With Bipolar Depression

    Share:
  • share via your computer's mail program
3-min watch


FACULTY CONTRIBUTOR

Portrait picture of Greg Mattingly, MD
Greg Mattingly, MD
Associate Clinical Professor
Washington University School of Medicine
President, Midwest Research Group
​President-elect, American Professional Society for ADHD and Related Disorders​
St Louis, MO

Recommended Next

Key Differences Between Tardive Dyskinesia and Drug-Induced Parkinsonism
Read More | 4-min read
Risk Factors for Tardive Dyskinesia — Is My Patient at Higher Risk?
Read More | 4-min read
Tardive Dyskinesia vs Drug-Induced Parkinsonism: Know the Difference to Make a Difference
Read More | 9-min read

    Share:

  • share via your computer's mail program
Neurocrine Biosciences logo
  • Privacy Policy |
  • Cookie Policy |
  • Terms & Conditions |
  • Accessibility
©2022 Neurocrine Biosciences, Inc. All Rights Reserved.
MED-MSL-TD-US-0249 v2 CP-TD-US-0744 v3 07/2022
The MIND-TD website and educational content were sponsored and co-developed by Neurocrine Biosciences, Inc. The faculty have been compensated by Neurocrine Biosciences. This non-CME program is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient. The content did not undergo peer review by Current Psychiatry.